--- title: "Hong Kong Stock Movement: MiniMax's Listing Ignites AI Healthcare, XUNFEIHEALTH's Stock Price Soars 14.71%" type: "News" locale: "en" url: "https://longbridge.com/en/news/272230659.md" description: "XUNFEIHEALTH rose 14.71%; Inspur Intelligent rose 13.40%, with a transaction volume of HKD 331 million; Yimaitong rose 12.65%, with a transaction volume of HKD 319 million; Brain 动极光-B rose 1.90%, with a transaction volume of HKD 309 million; Yidu Technology rose 11.17%, with a market value of HKD 6.958 billion" datetime: "2026-01-12T07:26:12.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/272230659.md) - [en](https://longbridge.com/en/news/272230659.md) - [zh-HK](https://longbridge.com/zh-HK/news/272230659.md) --- # Hong Kong Stock Movement: MiniMax's Listing Ignites AI Healthcare, XUNFEIHEALTH's Stock Price Soars 14.71% **Hong Kong Stock Movement** XUNFEIHEALTH rose 14.71%. Based on recent news, 1. On January 9, the domestic large model company MiniMax surged over 100% on its first day of listing, igniting artificial intelligence applications and driving up XUNFEIHEALTH's stock price. XUNFEIHEALTH's gains expanded to 25% at the end of trading, closing up 20.58% at HKD 97.55, with a transaction volume of HKD 190 million. Source: Zhitong Finance 2. On January 8, OpenAI launched the ChatGPT Health feature, which can answer health questions, connect smart devices, and plan diet and exercise, similar to "Ant Fortune." Dongbei Securities believes that large model manufacturers are further strengthening their layout in the medical field, which has become one of the key areas of focus, coupled with policy support, AI healthcare is expected to further develop. Source: Zhitong Finance 3. On January 11, the capital market is re-pricing AI companies, and XUNFEIHEALTH secured a national-level pilot base project, standing at a new competitive starting point. The popularity of health assistants is accelerating the industry, but the underlying system capabilities will still determine long-term outcomes. Source: Zhitong Finance AI healthcare field is intensively catalyzed, with continuous strengthening of policy support. **Stocks with High Trading Volume in the Industry** Insilico Medicine rose 13.40%. Based on recent key news: 1. On January 12, Insilico Medicine announced that its innovative candidate drug Garutadustat completed the first dosing of a subject in Phase IIa clinical trials. This drug, developed by the Pharma.AI platform, aims to treat inflammatory bowel disease and has a unique dual-action mechanism, driving up the stock price. Source: Economic Information Daily 2. On January 12, Insilico Medicine's drug Garutadustat received approval from the United States Adopted Names Council, further enhancing market confidence, leading to a rise in stock price. Source: Huigang Communications 3. On January 12, Insilico Medicine attracted high-profile investors including Eli Lilly, Tencent, and Temasek Holdings after its listing in Hong Kong, boosting market confidence in its future development. Source: WSJ The biotechnology industry is active in innovative drug research and development. Medical Pulse rose 12.65%, with a transaction volume reaching HKD 319 million, and no significant news recently. Trading is active, with clear capital flow; considering the sector and industry trends, this stock shows significant volatility, and specific reasons need further observation. Brainstorm Aurora-B rose 1.90%. Based on recent key news: 1. On January 12, Brainstorm Aurora-B recorded large trades in pre-market trading, with the transaction price 8.55% lower than the previous close, affecting stock price fluctuations. This transaction involved an amount of HKD 53.92 million, indicating increased market attention on this stock. 2. On January 8, shareholders of Brainstorm Aurora-B deposited shares into HSBC Hong Kong and Shanghai Banking Corporation, with a warehouse market value of HKD 742 million, accounting for 8.13%. This move may reflect shareholders' confidence in the company's future development, driving up the stock price 3. The interim performance of Brain 动极光-B as of June 30, 2025, shows a year-on-year revenue increase of 92.82%, but the net loss has also increased. Despite the widening losses, the revenue growth indicates the potential for business expansion, boosting market confidence. The Hong Kong stock market has recently experienced increased volatility, which needs attention. **Stocks ranked among the top in market capitalization in the industry** Yidu Technology, up 11.17%, with a market capitalization of HKD 6.958 billion, has no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation ### Related Stocks - [02506.HK](https://longbridge.com/en/quote/02506.HK.md) ## Related News & Research - [AI face is taking over — and driving plastic surgeons crazy](https://longbridge.com/en/news/286641783.md) - [06:07 ETStandardC Launches AI Platform for Financial Institutions, Where Customer PII Is Never Shared With AI Models (Patent Pending)](https://longbridge.com/en/news/286892045.md) - [Trillion-dollar Samsung faces a battle over who gets the AI profits](https://longbridge.com/en/news/287013238.md) - [11:30 ETDageno Launches Issues Panel and High-volume Prompt Miner to Help Growing Brands Turn AI Search Signals Into Growth Tasks](https://longbridge.com/en/news/286939643.md) - [Hippocratic AI Expands Life Sciences Leadership Team as Pharma and Medtech Demand for Voice AI Agents Accelerates](https://longbridge.com/en/news/287107640.md)